BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 35804954)

  • 21. Malignant Pleural Mesothelioma: Accuracy of CT Against Immunohistochemical Test Among the Mexican Population.
    Gopar-Nieto R; Aguilar-Madrid G; Sotelo-Martínez L; Juárez-Pérez CA; Kelly-García J; Argote-Greene L; Ochoa-Vázquez MD; García-Bazán EM; Ramírez-Pérez J; Haro-García L; Jiménez-Ramírez C; Cabello-López A
    Arch Med Res; 2015 Feb; 46(2):107-11. PubMed ID: 25707292
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biomarkers for early diagnosis of malignant mesothelioma: Do we need another moonshot?
    Lagniau S; Lamote K; van Meerbeeck JP; Vermaelen KY
    Oncotarget; 2017 Aug; 8(32):53751-53762. PubMed ID: 28881848
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasmatic extracellular vesicle microRNAs in malignant pleural mesothelioma and asbestos-exposed subjects suggest a 2-miRNA signature as potential biomarker of disease.
    Cavalleri T; Angelici L; Favero C; Dioni L; Mensi C; Bareggi C; Palleschi A; Rimessi A; Consonni D; Bordini L; Todaro A; Bollati V; Pesatori AC
    PLoS One; 2017; 12(5):e0176680. PubMed ID: 28472171
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clustering of malignant pleural mesothelioma in asbestos factories: a subgroup analysis in a 29-year follow-up study to identify high-risk industries in Taiwan.
    Lee LJ; Lin CK; Pan CH; Cheng Y; Chang YY; Liou SH; Wang JD
    BMJ Open; 2018 Dec; 8(12):e021063. PubMed ID: 30530573
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum concentration of integrin-linked kinase in malignant pleural mesothelioma and after asbestos exposure.
    Watzka SB; Posch F; Pass HI; Flores RM; Hannigan GE; Bernhard D; Weber M; Mueller MR
    Eur J Cardiothorac Surg; 2013 May; 43(5):940-5. PubMed ID: 23045294
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improved diagnosis and prognostication of patients with pleural malignant mesothelioma using biomarkers in pleural effusions and peripheral blood samples - a short report.
    Beije N; Kraan J; den Bakker MA; Maat APWM; van der Leest C; Cornelissen R; Van NM; Martens JWM; Aerts JGJV; Sleijfer S
    Cell Oncol (Dordr); 2017 Oct; 40(5):511-519. PubMed ID: 28577209
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Upcoming epidemic of asbestos-related malignant pleural mesothelioma in Taiwan: A prediction of incidence in the next 30 years.
    Lin RT; Chang YY; Wang JD; Lee LJ
    J Formos Med Assoc; 2019 Jan; 118(1 Pt 3):463-470. PubMed ID: 30072200
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combination of mesothelin and CEA significantly improves the differentiation between malignant pleural mesothelioma, benign asbestos disease, and lung cancer.
    Muley T; Dienemann H; Herth FJ; Thomas M; Meister M; Schneider J
    J Thorac Oncol; 2013 Jul; 8(7):947-51. PubMed ID: 23777840
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The degree of microRNA-34b/c methylation in serum-circulating DNA is associated with malignant pleural mesothelioma.
    Muraoka T; Soh J; Toyooka S; Aoe K; Fujimoto N; Hashida S; Maki Y; Tanaka N; Shien K; Furukawa M; Yamamoto H; Asano H; Tsukuda K; Kishimoto T; Otsuki T; Miyoshi S
    Lung Cancer; 2013 Dec; 82(3):485-90. PubMed ID: 24168922
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical significance of serum vascular endothelial growth factor in malignant pleural mesothelioma.
    Yasumitsu A; Tabata C; Tabata R; Hirayama N; Murakami A; Yamada S; Terada T; Iida S; Tamura K; Fukuoka K; Kuribayashi K; Nakano T
    J Thorac Oncol; 2010 Apr; 5(4):479-83. PubMed ID: 20357617
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mesothelioma Biomarkers: A Review Highlighting Contributions from the Early Detection Research Network.
    Pass HI; Alimi M; Carbone M; Yang H; Goparaju CM
    Cancer Epidemiol Biomarkers Prev; 2020 Dec; 29(12):2524-2540. PubMed ID: 32699075
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Droplet digital PCR as a novel system for the detection of microRNA‑34b/c methylation in circulating DNA in malignant pleural mesothelioma.
    Sato H; Soh J; Aoe K; Fujimoto N; Tanaka S; Namba K; Torigoe H; Shien K; Yamamoto H; Tomida S; Tao H; Okabe K; Kishimoto T; Toyooka S
    Int J Oncol; 2019 Jun; 54(6):2139-2148. PubMed ID: 30942424
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Malignant Pleural Mesothelioma Epidemiology in the United States From 2000 to 2016.
    Thomas A; Karakattu S; Cagle J; Hoskere G
    Cureus; 2021 Apr; 13(4):e14605. PubMed ID: 34040906
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroRNA-98 is a prognostic factor for asbestos-induced mesothelioma.
    Kim K; Ko Y; Oh H; Ha M; Kang J; Kwon EJ; Kang JW; Kim Y; Heo HJ; Kim G; Kim JW; Kim YH
    J Toxicol Environ Health A; 2020 Feb; 83(3):126-134. PubMed ID: 32114955
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New DNA Methylation Signals for Malignant Pleural Mesothelioma Risk Assessment.
    Cugliari G; Allione A; Russo A; Catalano C; Casalone E; Guarrera S; Grosso F; Ferrante D; Sculco M; La Vecchia M; Pirazzini C; Libener R; Mirabelli D; Magnani C; Dianzani I; Matullo G
    Cancers (Basel); 2021 May; 13(11):. PubMed ID: 34071989
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Soluble mesothelin-related peptide level elevation in mesothelioma serum and pleural effusions.
    Pass HI; Wali A; Tang N; Ivanova A; Ivanov S; Harbut M; Carbone M; Allard J
    Ann Thorac Surg; 2008 Jan; 85(1):265-72; discussion 272. PubMed ID: 18154821
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment patterns and outcomes for patients with malignant pleural mesothelioma in England in 2013-2017: A nationwide CAS registry analysis from the I-O Optimise initiative.
    Baas P; Daumont MJ; Lacoin L; Penrod JR; Carroll R; Venkatesan S; Ubhi H; Calleja A; Snee M
    Lung Cancer; 2021 Dec; 162():185-193. PubMed ID: 34823894
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical significance of soluble CD26 in malignant pleural mesothelioma.
    Fujimoto N; Ohnuma K; Aoe K; Hosono O; Yamada T; Kishimoto T; Morimoto C
    PLoS One; 2014; 9(12):e115647. PubMed ID: 25526639
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictions of Mortality from Pleural Mesothelioma in Italy After the Ban of Asbestos Use.
    Oddone E; Bollon J; Nava CR; Bugani M; Consonni D; Marinaccio A; Magnani C; Barone-Adesi F
    Int J Environ Res Public Health; 2020 Jan; 17(2):. PubMed ID: 31963601
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Rare Case of Malignant Pleural Mesothelioma in a Young Healthy Male Without Asbestos Exposure.
    Khatib S; Asad O; Asad H; Sabobeh T
    Cureus; 2021 Aug; 13(8):e17199. PubMed ID: 34540427
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.